POLICY RESOURCES

CHANGE Act

March 15, 2013

Stop Alzheimer's Before Symptoms Start? - Dr. Reisa Sperling

Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.

Dr. Sperling is the Director of the Center for Alzheimer's Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer's Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical School.

This call was made possible by the generous support of Jill Lesser, Board member of USAgainstAlzheimer's Network.

Join Us

Join Us today in the fight for a cure! Sign up to join UsA2 Networks and mailing lists that matter most to you and receive information with the latest news and updates.

Name

Email Address

Customize Your Interests

Sign up to receive communications on the latest research, newsletters and updates that interest you. Join our Communities for information on Networks that matter most to you.

Name

Email Address

Communication

General Email List

Monthly Update

Daily News Updates

Alzheimer's Talks

Our Communities

A-LIST

Activists

AD PACE

African Americans

Faith

Latinos

Researchers

Women

Veterans

Youth

Additional Information

We would like to learn more about you, and some of our Communities require additional information. Fill in your information below to ensure we have what we need to add you to our communications and Networks.

Name

Email Address

Title

Organization

Address

City

State

Thank You

For signing up with UsAgainstAlzheimer’s and joining our fight for a cure! You will begin to receive updates in the areas that interest you most.

More Alzheimer's Talks:

While Alzheimer's disease is most common among people aged 65 and older, research from AARP and UsAgainstAlzheimer's finds its effects are being felt more and more by young people. Our chief of staff and executive director of our LatinosAgainstAlzheimer's network, Jason Resendez, spoke with young people who are shaping the...

What if a blood test or other simple exam could one day detect Alzheimer’s? Scientists are in pursuit of ways to test for Alzheimer’s by measuring a biomarker—a substance in the body that may indicate or rule out the presence of a disease. This could make Alzheimer’s diagnosis more common...

For Veterans Day, our Alzheimer’s Talk focused on the Alzheimer’s risks that veterans face, the Department of Veterans Affairs research working to understand this connection, and the great VA care and services available to veterans living with Alzheimer’s, their care partners and their families. Some quick facts:

In July, at the world’s largest gathering of Alzheimer’s researchers, the 2018 Alzheimer’s Association International Conference (AAIC), thousands of researchers gathered to discuss the latest and best in Alzheimer’s research. What does the latest research have to say about disparities in Alzheimer’s and dementia impacting diverse communities? What were the...

Is there anything each of us can do to protect our cognitive function or even reduce our risk of Alzheimer’s? Just as we have found ways to reduce heart disease risk, scientists increasingly think there may be steps we can take to ward off Alzheimer’s.

Does research into new Alzheimer's treatments reflect what matters most to those living with the disease and to their care partners? When new drugs become available, will they make the changes in people’s lives that are most important to them—or only help people do better on cognitive tests but not improve ability...

Is depression or anxiety a risk factor for Alzheimer’s disease – or the other way around? For our May 2018 Talk, we spoke with Jennifer R. Gatchel, MD, PhD, a geriatric psychiatrist at Massachusetts General Hospital and an instructor in psychiatry at Harvard Medical School.

For National Minority Health Month, our April Alzheimer's Talks focused on a first-of-its-kind study that used tailored text messaging to boost Alzheimer’s knowledge in African Americans—who are up to three times more likely than non-Hispanic whites to get Alzheimer’s. Do the findings point to ways to improve health information-seeking and health...

For our December Alzheimer’s Talks, UsAgainstAlzheimer’s Chairman and Co-Founder George Vradenburg spoke with Lakelyn Hogan, a gerontologist and caregiver advocate at Home Instead Senior Care, where she educates professionals, families, and communities on issues that older adults and their families face. At HelpForAlzheimersFamilies.com, visitors can sign up for...

This Alzheimer’s Talks was in collaboration with our newest network, VeteransAgainstAlzheimer’s, and was moderated by Shawn Taylor, UsAgainstAlzheimer’s board member and president of our Veterans network. Our guest was Dr. David Cifu, Professor and Chairman of the Department of Physical Medicine and Rehabilitation at Virginia Commonwealth University School of Medicine,...

The guest on October’s Alzheimer’s Talks was Lisa Genova, a neuroscientist and author whose work explores what it is like to live with neurological diseases and disorders. Her bestselling books include Still Alice, Inside the O’Briens, Left Neglected, and Love Anthony. Still Alice, about a...

September’s Alzheimer’s Talks focused on the importance of clinical trials, particularly to better understand the motivations of and barriers to participation among diverse communities. This call was hosted by Jason Resendez, director of the LatinosAgainstAlzheimer’s network, and Dr. Goldie Byrd, Director of the Center for Outreach in Alzheimer’s Aging...

Dr. Laurie Ryan was our guest for the June Alzheimer’s Talks. Dr. Ryan is Chief of the Dementias of Aging Branch in the Division of Neuroscience at the National Institute on Aging, which is part of the National Institutes of Health (NIH). At the National Institute on Aging, she directs...

Author and journalist Greg O’Brien spoke about his journey into Alzheimer’s disease with Meryl Comer. Greg was diagnosed with early onset Alzheimer’s in 2009, and has been writing, chronicling, and talking about the process ever since. He shared his thoughts, strategies, and experiences in a candid and personal conversation.

For our February Alzheimer’s Talks, guest host Meryl Comer talked with Dr. Nathan Rose, Assistant Professor of Cognition Brain and Behavior in the Department of Psychology at the University of Notre Dame. Dr. Rose’s research focuses on basic memory processes and how these processes break down in aging and Alzheimer’s...

For the first Alzheimer’s Talks of 2017, we spoke with Dr. Scott Turner of Georgetown University to discuss a fascinating new clinical trial that is exploring the repurposing of an existing drug, as a potential new Alzheimer's treatment.

Dr. Turner is one of the nation’s foremost clinical researchers in Alzheimer’s. He is Professor...

For our final Alzheimer’s Talks call for 2016, we were honored to have Dr. Laura Baker join us to discuss her research on the impact of aerobic exercise on Alzheimer’s disease and memory loss, and to provide details of a new study she is conducting called the EXERT trial....

For our September Alzheimer’s Talks, we were honored to welcome Teepa Snow, a respected dementia and Alzheimer’s care expert with a background in occupational therapy and more than 35 years of experience in clinical practice.

Dr. Jeffrey Iliff spoke with UsAgainstAlzheimer's Co-Founder and Chairman George Vradenburg for our August Alzheimer’s Talks. Dr. Iliff is an Assistant Professor in the Department of Anesthesiology and Perioperative Medicine at Oregon Health & Science University and he was part of a team that discovered a critical brain-cleansing system.

Dr. Robert Rissman was our guest for the July Alzheimer’s Talks where he spoke about his research on the relationship between chronic stress and Alzheimer’s disease and his work to develop a biomarker for Alzheimer’s and prevent cognitive decline.

Dr. Rissman is Associate Professor of Neurosciences at the University of...

Dr. Eric Reiman, the Executive Director of Banner Alzheimer’s Institute, joined this Alzheimer’s Talks to discuss his research to prevent Alzheimer’s disease, including two clinical trials that the Alzheimer’s Prevention Initiative has underway and the need to recruit more people into Alzheimer's clinical trials to speed these efforts.

Journalist, radio talk show host, and author Diane Rehm spoke with UsAgainstAlzheimer's Co-Founder and Chairman George Vradenburg about her new book, On My Own, which is a deeply personal, profoundly moving, and incredibly honest book about her life before and after her husband’s death with Parkinson’s disease.

Drew Holzapfel, Director of ResearchersAgainstAlzheimer’s, and Dr. David Morgan, CEO of the Byrd Alzheimer’s Institute and a founding member of ResearchersAgainstAlzheimer’s, joined us for this month’s...

Dr. Lawrence Friedhoff from Axovant Sciences was our guest for this Alzheimer’s Talks. Dr. Friedhoff has worked in pharmaceutical research and development for more than thirty years. He has led teams that developed and obtained approval for six new drugs, including donepezil (commonly known as Aricept) and he is also...

During our January Alzheimer’s Talks, we were joined by Dan Gasby – the partner in marriage and business with B. Smith, the incredible woman who broke down barriers as a restaurant owner and model and is now facing the challenge of her life: Alzheimer’s disease. The two are doing all...

There is a strong connection between Down syndrome and Alzheimer’s disease, and understanding this connection has the potential to lead to major advances in preventing or treating Alzheimer’s – both for individuals with Down syndrome and for the population as a whole.

Though only about one percent of the population have a rare, genetically inherited form of Alzheimer’s disease, studies with this population give scientists great insight into how the disease works as well as ways to prevent and treat it in the general Alzheimer’s population.

Sixty percent of people with late-life depression also suffer from some form of cognitive impairment, and research shows depression is linked to a faster decline into dementia. But the mechanisms that connect depression and Alzheimer’s are still a mystery.

Some people say once a person has Alzheimer’s, he or she becomes a stranger, losing the pieces of his or her personality we knew and loved before. But when Dr. Harry Kozol, a respected psychiatrist and neurologist, was diagnosed, his son Jonathan Kozol was struck by his father’s resilience and...

Previous research has shown that NSAIDS, a class of anti-inflammatory drug, can help prevent Alzheimer’s in cognitively normal people, but it wasn’t clear why. NSAIDs do not work once any memory loss has begun, so this is a real preventive effect. Now, exciting new research has identified a potential culprit...

Five years after award-winning journalist Greg O’Brien was diagnosed with early onset Alzheimer’s—the same disease that stole his mother, grandfather, and uncle—he found that, at any given moment, he could be without 60 percent of his short-term memory. Greg has more than 35 years of newspaper...

Concussions and traumatic brain injury can actually be a risk factor for degenerative diseases, including Alzheimer’s.

Dr. Bruce L. Miller, Director of the Memory and Aging Center at the University of California San Francisco, is a behavioral neurologist focused on dementia. His work in frontotemporal dementia (FTD) emphasizes both the...

Senator Amy Klobuchar of Minnesota joined us at the top of the call to discuss her work in the Senate to stop Alzheimer’s – for example, increasing NIH funding for Alzheimer’s research as well as tax credits for caregivers – and the importance that these efforts be bipartisan. UsAgainstAlzheimer's is...

Dr. Rudy Tanzi has made headlines all over the world for leading the team that made a major breakthrough: They replicated Alzheimer’s outside of the brain. Dubbed “Alzheimer’s in a dish,” this discovery gives Dr. Tanzi, his team, and researchers around...

Professor at the University of California, San Francisco and Founder of the Brain Health Registry, Dr. Michael Weiner has long been at the forefront of discussions about how to improve Alzheimer’s research. Here are just some of the key points...

Dr. Reisa Sperling is leading a study into a new drug treatment that could prevent memory loss before symptoms show. The changes in the brain that lead to Alzheimer's occur years before symptoms, such as forgetfulness, appear. Dr. Sperling is leading the Anti-Amyloid Treatment in Asymptomatic Alzheimer's study (A4 study...

Researchers have discovered a first-of-its-kind blood test for Alzheimer's disease that can predict - with 90 percent accuracy - if a healthy person will develop this cruel disease within three years. Dr. Howard Federoff, the Executive Vice President for Health Sciences at Georgetown University Medical Center and Executive Dean of...

A discussion with Bernard Munos, Founder of InnoThink, and named one of the 25 most influential people in biopharma by FiercePharma. He discussed his analysis of the drug pipeline, the status of drugs in it, as well as his recommendations for how we can organize research more effectively and lower...

A discussion with Dr. Mark Burns, Assistant Professor of Neuroscience and Director of the Laboratory for Brain Injury and Dementia at Georgetown University, about his research on the link between traumatic brain injury (TBI) and Alzheimer's disease. This call was made possible by the generous support of Shawn Taylor, board...

A discussion with Dr. Steven Arnold, Professor of Psychiatry and Neurology, University of Pennsylvania and Director of the Penn Memory Center and Dr. Gary Landreth, Professor of Neurosciences and Neurology and Director, Alzheimer's Research Laboratory, Case Western Reserve University School of Medicine. Dr. Arnold is conducting research into...

Did you know that African Americans are twice as likely to develop Alzheimer's disease? We need to do all we can to eliminate this appalling health disparity – and the first step is to understand why it exists.

Dr. Frank LaFerla is Director of the Institute for Memory Impairments and Neurological Disorders, University of California, Irvine. He was the first to use stem cell technology for use in mice engineered for both the plaques and tangles that are characteristic of human Alzheimer’s disease. Recently, his group reported data...

Congress refuses to confront Alzheimer’s with the urgency it requires. That’s why USAgainstAlzheimer’s and dozens of other leading organizations in the Alzheimer’s community have launched a groundbreaking coalition effort to stop Alzheimer’s through an unprecedented petition effort. Click play to listen to a recording of this hour-long teleconference that took...

During the call, Mark Shriver discussed his new book, A Good Man: Rediscovering My Father, Sargent Shriver, followed by a Q&A session. This call was made possible by the generous support of the Zickler Family Foundation. Click play to listen to a recording of this hour-long teleconference that took...

For the first time ever, the US government has adopted a national strategic plan to prevent and effectively treat Alzheimer’s disease by 2025. Dr. Ron Petersen, Chairman of the National Alzheimer’s Advisory Council on Research, Care and Services and Director of the Mayo Clinic’s Alzheimer’s Disease Research Center summarized what...

We will not be able to find a cure for Alzheimer’s, until we understand what causes this horrible disease. Dr. Rudy Tanzi discussed what we know about the role of genetics and environment in Alzheimer’s and took questions from those on the call. Click play to listen to a recording...

Understanding — and accelerating — the drug pipeline is crucial to efforts to stop Alzheimer’s, whether you are a policymaker, work in Alzheimer’s research or care, or are one of the thousands of grassroots advocates across the nation. Click play to listen to a recording of this call that took...